WEG
VRTX icon

World Equity Group’s Vertex Pharmaceuticals VRTX Stock Holding History

World Equity Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-582
Closed -$234K – 384
2024
Q4 		$234K Buy
+582
New +$270K 0.05% 317
2023
Q2 		– Sell
-13,136
Closed -$531K – 561
2023
Q1 		$531K Buy
+13,136
New +$3.94M 0.08% 271
2022
Q2 		– Sell
-2,995
Closed -$782K – 403
2022
Q1 		$782K Buy
+2,995
New +$711K 0.17% 151

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

World Equity Group's VRTX Position: Q1 2025 in Review

World Equity Group sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 582 shares — an estimated $234K sold.

World Equity Group first reported a position in VRTX in Q1 2022 and held it in 3 quarters. The position peaked at $782K in Q1 2022. 1,612 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

  • World Equity Group reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • World Equity Group sold 582 Vertex Pharmaceuticals shares in Q1 2025, an estimated $234K.
  • World Equity Group first reported a position in Vertex Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • World Equity Group's Vertex Pharmaceuticals position peaked at $782K in Q1 2022.
  • 1,612 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on World Equity Group's 13F filing for Q1 2025, filed 22 Apr 2025.